Amate and OnabotulinumtoxinA. Combined together with the truth that the anti-CGRP monoclonal antibodies have, currently
Amate and OnabotulinumtoxinA. Combined together with the truth that the anti-CGRP monoclonal antibodies have, currently at this stage with a number of trials nevertheless ongoing, the highest number of patients…